Brief: Sino Biopharmaceutical Signs Equity Investment And Strategic Cooperation Agreement
20/11/2024 01:02
Nov 20 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* SIGNING EQUITY INVESTMENT AND STRATEGIC COOPERATION
AGREEMENT
WITH LANOVA MEDICINES
* DEAL FOR LM-108 IN MAINLAND CHINA REGION
Further company coverage: 1177.HK
Recent news on Sino Biopharmaceutical
See all newsBrief: Sino Biopharmaceutical Announces Share Purchase Plan For HK$2 Billion
Brief: Sino Biopharmaceutical Says Marketing Application For M701 Accepted By China In May 2026
Brief: Sino Biopharmaceutical Says Zongertinib Approved By NMPA China
GSK to team up with Sino Biopharma for China launch of hepatitis B treatment (updated)
HK-listed Sino Biopharmaceutical hits 2-week high on GSK tie-up